1. Review key action statements from 2022 Clinical Practice Guideline Revision for Management of Hyperbilirubinemia in Newborn Infants >/=35 weeks
2. Highlight key changes from previous guidelines including increased phototherapy thresholds, emphasis on evaluating for hemolysis, decrease unnecessary IV fluid use and decrease unnecessary rebound bilirubin draws after phototherapy in low-risk infants
3. Review updated NorthShore University HealthSystem’s hyperbilirubinemia guideline and work flow.
12/13/2022 - 8:00am to 9:00am CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Nicole Kafati, MD